期刊文献+

中国仓鼠卵巢工程细胞无血清流加培养关键工艺参数的考察

Evaluation of the critical process parameters for the cultivation of recombinant Chinese hamster ovary cells in serum-free fed-batch mode
原文传递
导出
摘要 主要考察流加培养基中不同营养成分、流加起始时间及初始接种密度对11G-S细胞无血清流加培养的影响。在研究中以悬浮适应的表达尿激酶原(Pro-urokinase,Pro-UK)CHO工程细胞系11G-S为研究对象,在100 mL的摇瓶中无血清悬浮流加培养11G-S细胞,同时以活细胞密度、细胞活力及Pro-UK活性为评价依据。结果表明在培养基中氨基酸、无血清添加成分及无机盐对促进细胞生长、细胞活力维持及蛋白表达起着较为重要的作用;且流加起始时间为72 h及初始接种密度为3×105~4×105 cells/mL的流加培养效果较好。在为期12 d的流加培养过程中,11G-S细胞的最大活细胞密度达到7.8×106 cells/mL,Pro-UK的最大累积活性为8 570 IU/mL。在此基础上,分别考察了无血清悬浮流加培养及分批培养11G-S细胞的生长及代谢特征,流加培养中期11G-S细胞的比生长速率(μ)高于同期批次培养的11G-S细胞;流加培养中后期11G-S细胞的葡萄糖比消耗速率(qglu)和谷氨酰胺比消耗速率(qgln)均高于同期批次培养的11G-S细胞。 Taking a suspension adapted recombinant CHO cell line,11G-S expressing human Pro-urokinase(Pro-UK) as the object of study,the impacts of different feeding nutrients,the start time of feeding and cell inoculation density on the growth and Pro-UK production of 11G-S cells in serum-free fed-batch culture were evaluated in 100 mL shacking flasks.The results indicated that amino acids,serum-free supplements and inorganic salts played important role in cell growth,cell viability and protein expression.And the effects of cells fed-batch culture was much better with the initial cell inoculation density at 3×105~4×105 cells/mL and the start time of feeding set at 72 h,a maximum viable cells density of 7.8×106 cells/mL with a peak Pro-UK activity at 8 570 IU/mL was achieved during 12 d fed-batch culture.Further,the of the 11G-S cells at the middle phase of the fed-batch culture,and both the qglu and qgln of the 11G-S cells at the middle and later phases of the fed-batch culture was higher than that of the 11G-S cells at the same phase of the batch culture,respectively.
出处 《生物工程学报》 CAS CSCD 北大核心 2011年第2期240-246,共7页 Chinese Journal of Biotechnology
基金 "重大新药创制"科技重大专项资助课题(No.2009ZX09503-011)资助~~
关键词 CHO工程细胞 无血清培养 流加培养 工艺参数 代谢特征 recombinant CHO cells serum free culture fed-batch culture process parameter metabolism character
  • 相关文献

参考文献13

  • 1Hesse F, Wagner R. Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures. Trends Biotechnol, 2000, 18(4): 173 180.
  • 2Fletcher T. Designing culture media for recombinant protein production: a rational approach. BioProcess International, 2005, 3(1): 30 -36.
  • 3Wlaschin KF, Hu WS. Fedbatch culture and dynamic nutrient feeding. Adv Biochem Eng Biotechnol, 2006, 101: 43-74.
  • 4Chu L, Robinson DK. Industrial choices for protein production by large-scale cell culture. Curr Opin Biotechnol, 2001, 12(2): 180-187.
  • 5Dingermann T. Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J, 2008, 3(1): 90-97.
  • 6Whitford WG. Fed-batch mammalian cell culture in bioproduction. BioProcess International, 2006, 4: 30-40.
  • 7lespersen J, Astrup T. A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Hamostasis, 1983, 13(5): 301-315.
  • 8De Alwis DM, Dutton RL, Scharer J, et al. Statistical methods in media optimization for batch and fed-batch animal cell culture. Bioproc Biosyst Eng, 2007, 30(2): 107-113.
  • 9Zhou WC, Rehm J, Europa A, et al. Alternation of mammalian cell metabolism by dynamic nutrient feeding. Cytotechnology, 1997, 24(2): 99-108.
  • 10Kuwae S, Ohda T, Tamashima H, et al. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells. J Biosci Bioeng, 2005, 100(5): 502-510.

二级参考文献41

  • 1Whitford W G. Fed- batch mammalian cell culture in bioproduction. BioProcess International, 2006, 4 : 30 - 40
  • 2Wlaschin K, Seth G, Hu W. Toward genomic cell culture engineering. Cytotechnology, 2006, 50:121 - 140
  • 3Griffin T I, Seth G, Xie H, et al. Advancing mammalian cell culture engineering using genome - scale technologies. Trends in Biotechnol, 2007, 25:400 -408
  • 4Kromenaker S J, Srienc F. Effect of lactic acid on the kinetics of growth and antibody production in a murine hybridoma secretion patters during the cell cycle. J Biotechnol, 1994,34:13 -34
  • 5Martinelle K, Haggstrom L. Mechanisms of ammonia and ammonium ion toxicity in animal cells: transport across cell membranes. J Biotechnol, 1993, 30:339 - 350
  • 6Glaken M W, Fleischaker R J, Sinskey A J. Reduction of waste product excretion via nutrient control: possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol Bioeng,1986, 28 : 1376 - 1389
  • 7Gambhir A, Korke R, Lee J, et al. Analysis of cellular metabolism of hybridoma cells at distint physiological states. J Biosci Bioeng,2003, 95 : 317 - 327
  • 8Chen K, Liu Q, Xie L Z,et al. Engineering of a mammalian cell line for reduction of lactate formation and high monoclonal antibody production. Biotechnol Bioeng,2001, 72:55 -61
  • 9Fogolin M B. Wagner R, Etcheverrigaray M, et al. Impact of temperature reduction and expression of yeast pyruvate carboxylase on hGM - CSF - producing CHO cells. J Biotechnol,2004,109 : 179 - 191
  • 10Barnes L M, Bentley C M, Dickson A J. Advances in animal cell recombinant protein production: GS - NS0 expression system. Cytotechnology,2000, 32 : 109 - 123

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部